Skip to main content
Log in

Experiments with tissue cultures from a human ovarian serous cystadenocarcinoma producing cancer antigen 125 (CA125), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA)

  • Originals
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Summary

The patient was a 57-year-old woman with ovarian serous cystadenocarcinoma in FIGO clinical stage IV. Cancer antigen 125 (CA 125), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) were immunohistochemically demonstrated in tumor cells, and the variations of serum CA125 and TPA levels reflected the clinical course. The tumor tissue obtained at exploratory laparotomy was minced with scissors, and transplanted subcutaneously into female nude mice for in vivo maintenance. The tumor cells from 5th generation nude mice were dispersed in Eagle's minimal essential medium supplemented with 10% fetal calf serum, and incubated in Falcon tissue culture dishes at 37°C in 5% CO2 in air for in vitro maintenance. The results were as follows: Histopathologically the tumor transplanted into nude mice showed a cystadenocarcinoma, which closely resembled the original human tumor. Immunohistochemically CA125, TPA and CEA were demonstrated in the tumor transplanted into nude mice as well as in the original human tumor. From the growth curve in nude mice, the doubling time was estimated to be about 3.5 days. Serum TPA levels in nude mice were increased in proportion to the tumor growth after transplantation, but serum levels CA125 and CEA were normal. The concentrations of CA125 and TPA were increased in the conditioned media compared with the control media, although the elevated values were decreased with subsequent passages. CEA concentrations in the conditioned media were unchanged.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bast RC, Feeney M jr, Lazarus H, Nadler LM (1981) Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest 68: 1331–1337

    Google Scholar 

  2. Björklund B, Björklund V (1957) Antigenicity of pooled human malignant and normal tissues by cyto-immunological technique: presence of an insoluble, heat-labile tumor antigen. Int Arch Allergy Appl Immunol 10: 153–184

    Google Scholar 

  3. DiSaia PJ, Morrow M, Kanabus J, Piechal W, Townsend DE (1975) Two new tissue culture lines from ovarian cancer. Gynecol Oncol 3: 215–219

    Google Scholar 

  4. Freedman RS, Pihl E, Kusyk C, Gallager HS, Rutledge F (1978) Characterization of an ovarian carcinoma cell line. Cancer 42: 2352–2359

    Google Scholar 

  5. Fukazawa I, Inaba N, Ota Y, Sato N, Shirotake S, Iwasawa H, Sato T, Takamizawa H, Wiklund B (1987) Serum levels of six tumor markers in patients with benign and malignant gynecological disease. Arch Gynecol 243: 61–68

    Google Scholar 

  6. Fukazawa I, Inaba N, Ota Y, Sato N, Shirotake S, Iwasawa H, Sato T, Takamizawa H, Wiklund B (1987) Relation between serum levels of tissue polypeptide antigen (TPA) and cancer antigen 125 (CA125) and their immunohistochemical identification in benign and malignant gynecological disease. Arch Gynecol 243: 41–50

    Google Scholar 

  7. Gey GO, Coffman WD, Kubicek MT (1952) Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Res 12: 264–265

    Google Scholar 

  8. Hsu SM, Raine L, Fanger H (1981) The use of avidin-biotinperoxidase complex (ABC) in immunoperoxidase technique—a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29: 577–580

    Google Scholar 

  9. Inaba N, Ishige H, Ijichi M, Sato N, Okawa R, Sekiya S, Shirotake S, Takamizawa H, Renk T, Bohn H (1982) Immunohistochemical detection of pregnancy-specific protein (SP1) and placenta-specific tissue proteins (PP5, PP10, PP11, and PP12) in ovarian adenocarcinomas. Oncodev Biol Med 3: 379–389

    Google Scholar 

  10. Kawabata M (1984) New establishment and characterization of a carcinoembryonic antigen (CEA)-producing cell line from a human carcinoma of the uterine cervix. Acta. Obstet Gynaecol Jpn 36: 2619–2628

    Google Scholar 

  11. Kidera Y, Yoshimura T, Ohkuma Y, Iwasaka T, Sugimori H (1985) Establishment and characterization of cell line derived from mucinous cystadenocarcinoma of human ovary. Acta Obstet Gynaecol Jpn 37: 1820–1824

    Google Scholar 

  12. Motoyama T (1981) Biological characterization including sensitivity to Mitomycin C of cultured human ovarian cancers. Acta Obstet Gynaecol Jpn 33: 1197–1204

    Google Scholar 

  13. Uehara S, Soh K, Hoshiai H, Yajima A, Suzuki M (1983) Establishment and characterization of human ovarian endometrioid carcinoma cell line. Acta Obstet Gynaecol Jpn 35: 19–26

    Google Scholar 

  14. Woods LK, Morgan RT, Quinn LA, Moore GE, Semple TU, Stedman KE (1979) Comparison of four new cell lines from patients with adenocarcinoma of the ovary. Cancer Res 39: 4449–4459

    Google Scholar 

  15. Yamada T (1974) The cellular biology of a newly established cell line of human ovarian adenocarcinoma in vitro. Keio J Med 23: 53–70

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fukazawa, I., Inaba, N., Ota, Y. et al. Experiments with tissue cultures from a human ovarian serous cystadenocarcinoma producing cancer antigen 125 (CA125), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA). Arch Gynecol Obstet 243, 69–81 (1988). https://doi.org/10.1007/BF00932972

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00932972

Key words

Navigation